Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care therapies (investigator’s choice), resulting in an ...

Silevertinib shows robust antitumor and CNS activity in NSCLC patients with nonclassical EGFR mutations, achieving a 60% ORR and 86% CNS ORR. The disease control rate is 91%, with manageable adverse ...

The United Nations Security Council on Monday approved a US-drafted resolution endorsing President Donald Trump's 20-point plan for the devastated Gaza Strip. Authorising an International ...

Marie Selby Botanical Gardens has announced that the official groundbreaking ceremony for Phase Two of its three-phase master plan for its downtown Sarasota campus will take place on Tuesday, Dec. 2, ...

Myanmar’s junta-appointed election commission announced on Tuesday that the second phase of the regime-organized election will be held on Jan. 11, 2026 in another 100 townships—nearly half of which ...

As power density soars, air and single-phase loops hit their limits. A new webinar from Advanced Cooling technologies (ACT) shows how loop thermosyphons and pumped two-phase cooling unlock higher ...

Has a camouflaged athlete running on a dirt road ever shouted health advice through your phone? Sometimes these videos are motivational and get you off the couch to start exercising; sometimes they’re ...

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of treatment, compared with standard-of-care (SoC) treatments ...

As one of the cutting-edge research areas in modern physics, space-based gravitational wave detection aims at capturing gravitational wave signals in the mHz frequency band. A key technological ...

Jesse Zanger is the managing editor of CBSNewYork.com. Jesse has previously worked for the Fox News Channel and Spectrum News NY1. He covers regional news around the Tri-State Area, with a particular ...